Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in JAMA Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

January 2018
1. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
   Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
   JAMA. 2018;319:241-254.
   PubMed     Text format     Abstract available
   
   
   December 2017
2. GREENLAND P
   Cardiovascular Guideline Skepticism vs Lifestyle Realism?
   JAMA. 2017 Dec 14. pii: 2666625. doi: 10.1001/jama.2017.19675.
   PubMed     Text format    
   
   
   August 2017
3. FERENCE BA, Kastelein JJP, Ginsberg HN, Chapman MJ, et al
   Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
   JAMA. 2017 Aug 28. doi: 10.1001/jama.2017.11467.
   PubMed     Text format     Abstract available
   
   
   
4. KAZI DS, Penko J, Coxson PG, Moran AE, et al
   Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.
   JAMA. 2017;318:748-750.
   PubMed     Text format    
   
   
   
5. KRUMHOLZ HM
   Treatment of Cholesterol in 2017.
   JAMA. 2017;318:417-418.
   PubMed     Text format    
   
   
   July 2017
6. KNOWLES JW, Rader DJ, Khoury MJ
   Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
   JAMA. 2017;318:381-382.
   PubMed     Text format    
   
   
   
7. IOANNIDIS JPA
   Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.
   JAMA. 2017 Jul 24. doi: 10.1001/jama.2017.6765.
   PubMed     Text format    
   
   
   
8. GROSSMAN DC, Bibbins-Domingo K, Curry SJ, Barry MJ, et al
   Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement.
   JAMA. 2017;318:167-174.
   PubMed     Text format     Abstract available
   
   
   
9. PATNODE CD, Evans CV, Senger CA, Redmond N, et al
   Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Tas
   JAMA. 2017;318:175-193.
   PubMed     Text format     Abstract available
   
   
   April 2017
10. SCHWARTZ MLB, Williams MS, Murray MF
    Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance.
    JAMA. 2017;317:1527-1528.
    PubMed     Text format    
    
    
    
11. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Text format     Abstract available
    
    
    November 2016
12. BIBBINS-DOMINGO K, Grossman DC, Curry SJ, Davidson KW, et al
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2016;316:1997-2007.
    PubMed     Text format     Abstract available
    
    
    August 2016
13. KAZI DS, Moran AE, Coxson PG, Penko J, et al
    Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    JAMA. 2016;316:743-53.
    PubMed     Text format     Abstract available
    
    
    
14. LOZANO P, Henrikson NB, Dunn J, Morrison CC, et al
    Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:645-55.
    PubMed     Text format     Abstract available
    
    
    
15. LOZANO P, Henrikson NB, Morrison CC, Dunn J, et al
    Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:634-44.
    PubMed     Text format     Abstract available
    
    
    
16. BIBBINS-DOMINGO K, Grossman DC, Curry SJ, Davidson KW, et al
    Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2016;316:625-33.
    PubMed     Text format     Abstract available
    
    
    
17. URBINA EM, de Ferranti SD
    Lipid Screening in Children and Adolescents.
    JAMA. 2016;316:589-91.
    PubMed     Text format    
    
    
    April 2016
18. NISSEN SE, Stroes E, Dent-Acosta RE, Rosenson RS, et al
    Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    JAMA. 2016;315:1580-90.
    PubMed     Text format     Abstract available
    
    
    
19. WATERS DD, Hsue PY, Bangalore S
    PCSK9 Inhibitors for Statin Intolerance?
    JAMA. 2016;315:1571-2.
    PubMed     Text format    
    
    
    March 2016
20. SHRANK WH, Barlow J
    New Strategies to Treat High Cholesterol--Reply.
    JAMA. 2016;315:1169-70.
    PubMed     Text format    
    
    
    
21. BLUM CB, Stone NJ
    New Strategies to Treat High Cholesterol.
    JAMA. 2016;315:1169.
    PubMed     Text format    
    
    
    December 2015
22. JIN J
    JAMA PATIENT PAGE. PCSK9 Inhibitors for Treating High Cholesterol.
    JAMA. 2015;314:2320.
    PubMed     Text format    
    
    
    November 2015
23. PURSNANI A, Massaro JM, Hoffmann U
    Predicted vs Observed Clinical Event Risk for Cardiovascular Disease-Reply.
    JAMA. 2015;314:2082-2083.
    PubMed     Text format    
    
    
    
24. DEFILIPPIS AP, Blaha MJ
    Predicted vs Observed Clinical Event Risk for Cardiovascular Disease.
    JAMA. 2015;314:2082.
    PubMed     Text format    
    
    
    October 2015
25. SHRANK WH, Barlow JF, Brennan TA
    New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines.
    JAMA. 2015;314:1443-4.
    PubMed     Text format    
    
    
    
26. GANDA OP
    Failure to Report Financial Disclosure Information.
    JAMA. 2015;314:1404.
    PubMed     Text format    
    
    
    July 2015
27. MITKA M
    Exploring Statins to Decrease HIV-Related Heart Disease Risk.
    JAMA. 2015 Jul 29. doi: 10.1001/jama.2015.5498.
    PubMed     Text format    
    
    
    
28. PURSNANI A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, et al
    Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    JAMA. 2015;314:134-41.
    PubMed     Text format     Abstract available
    
    
    
29. GREENLAND P, Lauer MS
    Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.
    JAMA. 2015;314:127-8.
    PubMed     Text format    
    
    
    June 2015
30. GANDA OP
    Clinician Understanding of Cholesterol Treatment Guidelines--Reply.
    JAMA. 2015;313:2382.
    PubMed     Text format    
    
    
    
31. LEE TC, McDonald EG
    Clinician Understanding of Cholesterol Treatment Guidelines.
    JAMA. 2015;313:2381-2.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: